111 related articles for article (PubMed ID: 8196705)
1. Elimination of superfluous neuromuscular junctions in rat calf muscles recovering from botulinum toxin-induced paralysis.
Hassan SM; Jennekens FG; Wieneke G; Veldman H
Muscle Nerve; 1994 Jun; 17(6):623-31. PubMed ID: 8196705
[TBL] [Abstract][Full Text] [Related]
2. Neural cell adhesion molecule is required for stability of reinnervated neuromuscular junctions.
Chipman PH; Franz CK; Nelson A; Schachner M; Rafuse VF
Eur J Neurosci; 2010 Jan; 31(2):238-49. PubMed ID: 20074227
[TBL] [Abstract][Full Text] [Related]
3. Role and expression of thrombin receptor PAR-1 in muscle cells and neuromuscular junctions during the synapse elimination period in the neonatal rat.
Lanuza MA; Garcia N; González CM; Santafé MM; Nelson PG; Tomas J
J Neurosci Res; 2003 Jul; 73(1):10-21. PubMed ID: 12815704
[TBL] [Abstract][Full Text] [Related]
4. Ectopic expression of NCAM in skeletal muscle of transgenic mice results in terminal sprouting at the neuromuscular junction and altered structure but not function.
Walsh FS; Hobbs C; Wells DJ; Slater CR; Fazeli S
Mol Cell Neurosci; 2000 Mar; 15(3):244-61. PubMed ID: 10736202
[TBL] [Abstract][Full Text] [Related]
5. Juvenile and adult rat neuromuscular junctions: density, distribution, and morphology.
Ma J; Smith BP; Smith TL; Walker FO; Rosencrance EV; Koman LA
Muscle Nerve; 2002 Dec; 26(6):804-9. PubMed ID: 12451605
[TBL] [Abstract][Full Text] [Related]
6. Synapse elimination from the mouse neuromuscular junction in vitro: a non-Hebbian activity-dependent process.
Nelson PG; Fields RD; Yu C; Liu Y
J Neurobiol; 1993 Nov; 24(11):1517-30. PubMed ID: 8283186
[TBL] [Abstract][Full Text] [Related]
7. Sprouting of frog motor nerve terminals after long-term paralysis by botulinum type A toxin.
Diaz J; Molgó J; Pécot-Dechavassine M
Neurosci Lett; 1989 Jan; 96(2):127-32. PubMed ID: 2784552
[TBL] [Abstract][Full Text] [Related]
8. Morphology and molecular organization of the adult neuromuscular junction of Drosophila.
Rivlin PK; St Clair RM; Vilinsky I; Deitcher DL
J Comp Neurol; 2004 Jan; 468(4):596-613. PubMed ID: 14689489
[TBL] [Abstract][Full Text] [Related]
9. Interactions between nerve and muscle: synapse elimination at the developing neuromuscular junction.
Colman H; Lichtman JW
Dev Biol; 1993 Mar; 156(1):1-10. PubMed ID: 8449362
[TBL] [Abstract][Full Text] [Related]
10. The pupillary effects of retrobulbar injection of botulinum toxin A (oculinum) in albino rats.
Levy Y; Kremer I; Shavit S; Korczyn AD
Invest Ophthalmol Vis Sci; 1991 Jan; 32(1):122-5. PubMed ID: 1987093
[TBL] [Abstract][Full Text] [Related]
11. [Experimental and pathological changes of the neuromuscular junction].
Koenig J; Bauché S; Ben Ammar A; Nicolle D; Rigoard P; Eymard B; Hantaï D
Neurochirurgie; 2009 Mar; 55 Suppl 1():S104-9. PubMed ID: 19211115
[TBL] [Abstract][Full Text] [Related]
12. Botulinum neurotoxin serotype D is poorly effective in humans: an in vivo electrophysiological study.
Eleopra R; Montecucco C; Devigili G; Lettieri C; Rinaldo S; Verriello L; Pirazzini M; Caccin P; Rossetto O
Clin Neurophysiol; 2013 May; 124(5):999-1004. PubMed ID: 23245668
[TBL] [Abstract][Full Text] [Related]
13. The adult abdominal neuromuscular junction of Drosophila: a model for synaptic plasticity.
Hebbar S; Hall RE; Demski SA; Subramanian A; Fernandes JJ
J Neurobiol; 2006 Sep; 66(10):1140-55. PubMed ID: 16838368
[TBL] [Abstract][Full Text] [Related]
14. Long-term changes in myosin heavy chain composition after botulinum toxin a injection into rat medial rectus muscle.
Kranjc BS; Sketelj J; D'Albis A; Erzen I
Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3158-64. PubMed ID: 11726617
[TBL] [Abstract][Full Text] [Related]
15. Quantifying how location and dose of botulinum toxin injections affect muscle paralysis.
Shaari CM; Sanders I
Muscle Nerve; 1993 Sep; 16(9):964-9. PubMed ID: 8355728
[TBL] [Abstract][Full Text] [Related]
16. Trophic interrelations at the neuromuscular junction as revealed by the use of botulinal neurotoxins.
Thesleff S; Molgó J; Tågerud S
J Physiol (Paris); 1990; 84(2):167-73. PubMed ID: 2290131
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of botulinum neurotoxin types A and E at the rat neuromuscular junction.
Sellin LC; Kauffman JA; Dasgupta BR
Med Biol; 1983 Apr; 61(2):120-5. PubMed ID: 6308364
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of neural cell adhesion molecule (NCAM) antigens on intestinal smooth muscles in hypoganglionosis: is hypoganglionosis a disorder of the neuromuscular junction?
Kobayashi H; Li Z; Yamataka A; Lane GJ; Miyano T
Pediatr Surg Int; 2003 May; 19(3):190-3. PubMed ID: 12811479
[TBL] [Abstract][Full Text] [Related]
19. Quantifying the spread of botulinum toxin through muscle fascia.
Shaari CM; George E; Wu BL; Biller HF; Sanders I
Laryngoscope; 1991 Sep; 101(9):960-4. PubMed ID: 1886444
[TBL] [Abstract][Full Text] [Related]
20. The effects in the mouse of nerve crush and regneration on the innervation of skeletal muscles paralysed by Clostridium botulinum toxin.
Duchen LW
J Pathol; 1970 Sep; 102(1):9-14. PubMed ID: 4926981
[No Abstract] [Full Text] [Related]
[Next] [New Search]
